| Characteristics |
|
| Age in years, mean (SD*) copy | 34 (18.0) |
| Length of stay in days, mean (SD) | 36.0 (19.4) |
| Sex, % male (n) | 52.0 (13) |
| Baseline disease, % (n) |
|
| Leukemiaa | 32.0 (8) |
| Bone marrow failure and hemoglobinopathiesb | 28.0 (7) |
| Multiple myeloma | 20.0 (5) |
| Lymphoma | 12.0 (3) |
| Systemic sclerosis | 8.0 (2) |
| Type of HSCT, % (n) |
|
| Autologous for onco-hematological disease | 44.0 (11) |
| Autologous for autoimmune disease | 8.0 (2) |
| Related allogeneic HLA-matched | 36.0 (9) |
| Related allogeneic haploidentical | 12.0 (3) |
| Type of chemotherapy conditioning regimens, % (n) |
|
| Low intensityb | 32.0 (8) |
| Medium intensityc | 12.0 (3) |
| High intensityd | 56.0 (14) |